Bowie Capital Management LLC reduced its position in Colgate-Palmolive Company (NYSE:CL) by 1.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 168,000 shares of the company’s stock after selling 2,000 shares during the period. Colgate-Palmolive accounts for about 3.3% of Bowie Capital Management LLC’s investment portfolio, making the stock its 4th biggest position. Bowie Capital Management LLC’s holdings in Colgate-Palmolive were worth $12,454,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CL. Vanguard Group Inc. raised its position in Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after purchasing an additional 1,621,392 shares during the period. First Eagle Investment Management LLC raised its position in Colgate-Palmolive by 2.3% during the second quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock valued at $362,580,000 after purchasing an additional 108,850 shares during the period. TIAA CREF Investment Management LLC raised its position in Colgate-Palmolive by 3.7% during the second quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock valued at $350,267,000 after purchasing an additional 170,053 shares during the period. Fiera Capital Corp raised its position in Colgate-Palmolive by 17.3% during the second quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock valued at $340,662,000 after purchasing an additional 677,657 shares during the period. Finally, Legal & General Group Plc raised its position in Colgate-Palmolive by 2.2% during the second quarter. Legal & General Group Plc now owns 4,390,317 shares of the company’s stock valued at $325,461,000 after purchasing an additional 96,427 shares during the period. Institutional investors own 73.46% of the company’s stock.

Colgate-Palmolive Company (CL) opened at $71.75 on Thursday. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market capitalization of $63,416.76, a P/E ratio of 25.16, a P/E/G ratio of 3.31 and a beta of 0.80. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The company had revenue of $3.97 billion for the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the firm earned $0.73 earnings per share. Colgate-Palmolive’s revenue was up 2.8% compared to the same quarter last year. analysts expect that Colgate-Palmolive Company will post 2.88 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 annualized dividend and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 61.78%.

In other Colgate-Palmolive news, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the sale, the chief marketing officer now owns 45,217 shares in the company, valued at $3,313,501.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the company’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the sale, the director now owns 36,268 shares of the company’s stock, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. In the last three months, insiders sold 173,673 shares of company stock worth $12,629,293. 1.02% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: This piece was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/bowie-capital-management-llc-has-12-45-million-position-in-colgate-palmolive-company-cl/1721053.html.

A number of brokerages have issued reports on CL. Jefferies Group LLC restated a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Macquarie began coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective on the stock. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research report on Sunday, October 8th. Finally, Citigroup Inc. decreased their price objective on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research report on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $76.67.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.